1. Home
  2. ASMB vs PESI Comparison

ASMB vs PESI Comparison

Compare ASMB & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • PESI
  • Stock Information
  • Founded
  • ASMB 2005
  • PESI 1990
  • Country
  • ASMB United States
  • PESI United States
  • Employees
  • ASMB N/A
  • PESI N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • PESI Environmental Services
  • Sector
  • ASMB Health Care
  • PESI Industrials
  • Exchange
  • ASMB Nasdaq
  • PESI Nasdaq
  • Market Cap
  • ASMB 198.6M
  • PESI 205.4M
  • IPO Year
  • ASMB 2010
  • PESI 1992
  • Fundamental
  • Price
  • ASMB $21.85
  • PESI $9.12
  • Analyst Decision
  • ASMB Strong Buy
  • PESI
  • Analyst Count
  • ASMB 4
  • PESI 0
  • Target Price
  • ASMB $41.33
  • PESI N/A
  • AVG Volume (30 Days)
  • ASMB 148.4K
  • PESI 268.7K
  • Earning Date
  • ASMB 11-06-2025
  • PESI 11-12-2025
  • Dividend Yield
  • ASMB N/A
  • PESI N/A
  • EPS Growth
  • ASMB N/A
  • PESI N/A
  • EPS
  • ASMB N/A
  • PESI N/A
  • Revenue
  • ASMB $33,247,000.00
  • PESI $60,019,000.00
  • Revenue This Year
  • ASMB $12.44
  • PESI $8.35
  • Revenue Next Year
  • ASMB N/A
  • PESI $82.81
  • P/E Ratio
  • ASMB N/A
  • PESI N/A
  • Revenue Growth
  • ASMB 54.77
  • PESI N/A
  • 52 Week Low
  • ASMB $7.75
  • PESI $6.25
  • 52 Week High
  • ASMB $27.17
  • PESI $16.25
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 40.57
  • PESI 33.79
  • Support Level
  • ASMB $22.36
  • PESI $8.02
  • Resistance Level
  • ASMB $23.61
  • PESI $12.32
  • Average True Range (ATR)
  • ASMB 1.30
  • PESI 0.82
  • MACD
  • ASMB -0.60
  • PESI -0.37
  • Stochastic Oscillator
  • ASMB 3.37
  • PESI 25.58

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

Share on Social Networks: